Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl CCNU

Lawrence Einhorn, B. Furnas

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Thirty patients with disseminated melanoma were treated with DTIC (250 mg/m2 for 5 consecutive days every 3 wk), methyl-CCNU (175 mg/m2 orally every 6 wk), and vincristine (1.4 mg/m2 weekly x 6 and then every 3 wk). Seven patients died within 3 wk of the start of chemotherapy. There was a 30% response rate (7 partial and two complete remissions) for all patients and a 39% response for evaluable patients. The median survival was 45 and 18 wk respectively for responders versus non-responders and 22 wk for all evaluable patients.

Original languageEnglish
Pages (from-to)881-883
Number of pages3
JournalCancer Treatment Reports
Volume61
Issue number5
StatePublished - 1977

Fingerprint

Semustine
Dacarbazine
Vincristine
Combination Drug Therapy
Melanoma
Drug Therapy
Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl CCNU. / Einhorn, Lawrence; Furnas, B.

In: Cancer Treatment Reports, Vol. 61, No. 5, 1977, p. 881-883.

Research output: Contribution to journalArticle

@article{e7fb0e1cf9434aa6accaa328cadeec7a,
title = "Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl CCNU",
abstract = "Thirty patients with disseminated melanoma were treated with DTIC (250 mg/m2 for 5 consecutive days every 3 wk), methyl-CCNU (175 mg/m2 orally every 6 wk), and vincristine (1.4 mg/m2 weekly x 6 and then every 3 wk). Seven patients died within 3 wk of the start of chemotherapy. There was a 30{\%} response rate (7 partial and two complete remissions) for all patients and a 39{\%} response for evaluable patients. The median survival was 45 and 18 wk respectively for responders versus non-responders and 22 wk for all evaluable patients.",
author = "Lawrence Einhorn and B. Furnas",
year = "1977",
language = "English",
volume = "61",
pages = "881--883",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl CCNU

AU - Einhorn, Lawrence

AU - Furnas, B.

PY - 1977

Y1 - 1977

N2 - Thirty patients with disseminated melanoma were treated with DTIC (250 mg/m2 for 5 consecutive days every 3 wk), methyl-CCNU (175 mg/m2 orally every 6 wk), and vincristine (1.4 mg/m2 weekly x 6 and then every 3 wk). Seven patients died within 3 wk of the start of chemotherapy. There was a 30% response rate (7 partial and two complete remissions) for all patients and a 39% response for evaluable patients. The median survival was 45 and 18 wk respectively for responders versus non-responders and 22 wk for all evaluable patients.

AB - Thirty patients with disseminated melanoma were treated with DTIC (250 mg/m2 for 5 consecutive days every 3 wk), methyl-CCNU (175 mg/m2 orally every 6 wk), and vincristine (1.4 mg/m2 weekly x 6 and then every 3 wk). Seven patients died within 3 wk of the start of chemotherapy. There was a 30% response rate (7 partial and two complete remissions) for all patients and a 39% response for evaluable patients. The median survival was 45 and 18 wk respectively for responders versus non-responders and 22 wk for all evaluable patients.

UR - http://www.scopus.com/inward/record.url?scp=0017713820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017713820&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 881

EP - 883

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 5

ER -